FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2136360447> ?p ?o ?g. }

• W2136360447 endingPage "3527" @default.
• W2136360447 startingPage "3513" @default.
• W2136360447 abstract "In general, the failing human heart is characterized by a selective reduction in β1-adrenoceptors (β1-ARs) without change in β2-AR density. Medical imaging techniques, either single photon emission computed tomography (SPECT) or positron emission tomography (PET) with appropriate radioligands, offer the possibility of assessing β-adrenoceptor density non-invasively in humans. To date, neither a SPECT nor a PET radioligand is available for the selective imaging of cardiac β1-ARs. The aim of this study was to develop potential high affinity β1-selective AR radioligands for the non-invasive in vivo imaging of the β1-AR density in the human heart using SPECT or PET. A variety of racemic N-aryl-N′-[2-[3-aryloxy-2-hydroxy-propylamino]-ethyl]-urea derivatives and chain-elongated analogues, related to the established β1-AR antagonist, ICI 89,406 8i, were synthesized. Competition studies using the non-selective AR ligand, [125I]iodocyanopindolol ([125I]ICYP), and ventricular membrane preparations of wild-type mice revealed nine ligands with higher β1-AR affinities (up to 76-fold) and β1-AR selectivities (up to 139-fold) than 8i. Mostly, these ligands possess a 2-substituted phenoxy group and a 4-substituted phenyl residue in contrast to the lead compound 8i. The non-radioactive counterparts of the desired SPECT- and PET-radiotracers were synthesized as reference compounds [e.g., 8f, 8g, 8h and 8l as the non-radioactive analogues of the radioiodinated SPECT radioligands, 8e and 8h as the non-radioactive compounds of C-11 labelled PET-tracers (C-11 in the methoxy group)]. The established library of high affinity β1-selective AR antagonists was screened for chemical precursors for the radiosynthesis of the mentioned radioligands. Furthermore, the library consists of some comparison compounds that are unsubstituted, allyl- and alkyl-substituted or chain-elongated (e.g., 8a, 8j, 8o and 8r–t). Future steps will include radiolabelling and pharmacokinetic evaluation of the β1-selective target compounds, which could be applied as sympathetic innervation agents for in vivo investigations and diagnostics in patients suffering from cardiac diseases like heart failure and ventricular arrhythmias." @default.
• W2136360447 created "2016-06-24" @default.
• W2136360447 creator A5042184078 @default.
• W2136360447 date "2003-08-05" @default.
• W2136360447 modified "2023-09-27" @default.
• W2136360447 title "Design of new β1-selective adrenoceptor ligands as potential radioligands for in vivo imaging" @default.
• W2136360447 cites W1924071370 @default.
• W2136360447 cites W1948948667 @default.
• W2136360447 cites W1963996103 @default.
• W2136360447 cites W1965912906 @default.
• W2136360447 cites W1975885446 @default.
• W2136360447 cites W1981103653 @default.
• W2136360447 cites W1983649348 @default.
• W2136360447 cites W1983713857 @default.
• W2136360447 cites W1985820664 @default.
• W2136360447 cites W1985955509 @default.
• W2136360447 cites W1996677049 @default.
• W2136360447 cites W1996972993 @default.
• W2136360447 cites W1997035340 @default.
• W2136360447 cites W1997541816 @default.
• W2136360447 cites W1999258270 @default.
• W2136360447 cites W2001574622 @default.
• W2136360447 cites W2003826829 @default.
• W2136360447 cites W2014366401 @default.
• W2136360447 cites W2015912619 @default.
• W2136360447 cites W2024483822 @default.
• W2136360447 cites W2035050298 @default.
• W2136360447 cites W2044403858 @default.
• W2136360447 cites W2045101857 @default.
• W2136360447 cites W2047926943 @default.
• W2136360447 cites W2052340849 @default.
• W2136360447 cites W2052367351 @default.
• W2136360447 cites W2056990901 @default.
• W2136360447 cites W2061816468 @default.
• W2136360447 cites W2066487213 @default.
• W2136360447 cites W2071070007 @default.
• W2136360447 cites W2074631079 @default.
• W2136360447 cites W2078983605 @default.
• W2136360447 cites W2079668285 @default.
• W2136360447 cites W2082204063 @default.
• W2136360447 cites W2090119198 @default.
• W2136360447 cites W2094224306 @default.
• W2136360447 cites W2097149135 @default.
• W2136360447 cites W2111047653 @default.
• W2136360447 cites W2113302341 @default.
• W2136360447 cites W2132783992 @default.
• W2136360447 cites W2161199570 @default.
• W2136360447 cites W2219950168 @default.
• W2136360447 cites W2285843642 @default.
• W2136360447 cites W2315695045 @default.
• W2136360447 cites W2413672541 @default.
• W2136360447 cites W2949760899 @default.
• W2136360447 cites W2908565535 @default.
• W2136360447 doi "https://doi.org/10.1016/s0968-0896(03)00297-9" @default.
• W2136360447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12878144" @default.
• W2136360447 hasPublicationYear "2003" @default.
• W2136360447 type Work @default.
• W2136360447 sameAs 2136360447 @default.
• W2136360447 citedByCount "23" @default.
• W2136360447 countsByYear W21363604472012 @default.
• W2136360447 countsByYear W21363604472014 @default.
• W2136360447 countsByYear W21363604472016 @default.
• W2136360447 countsByYear W21363604472017 @default.
• W2136360447 countsByYear W21363604472019 @default.
• W2136360447 countsByYear W21363604472021 @default.
• W2136360447 crossrefType "journal-article" @default.
• W2136360447 hasAuthorship W2136360447A5042184078 @default.
• W2136360447 hasConcept C116569031 @default.
• W2136360447 hasConcept C150903083 @default.
• W2136360447 hasConcept C170493617 @default.
• W2136360447 hasConcept C177322064 @default.
• W2136360447 hasConcept C185592680 @default.
• W2136360447 hasConcept C202751555 @default.
• W2136360447 hasConcept C207001950 @default.
• W2136360447 hasConcept C26291073 @default.
• W2136360447 hasConcept C2775842073 @default.
• W2136360447 hasConcept C2776970183 @default.
• W2136360447 hasConcept C2780231548 @default.
• W2136360447 hasConcept C29331040 @default.
• W2136360447 hasConcept C2984398910 @default.
• W2136360447 hasConcept C2989005 @default.
• W2136360447 hasConcept C3017724952 @default.
• W2136360447 hasConcept C55493867 @default.
• W2136360447 hasConcept C67847695 @default.
• W2136360447 hasConcept C71240020 @default.
• W2136360447 hasConcept C71924100 @default.
• W2136360447 hasConcept C86803240 @default.
• W2136360447 hasConceptScore W2136360447C116569031 @default.
• W2136360447 hasConceptScore W2136360447C150903083 @default.
• W2136360447 hasConceptScore W2136360447C170493617 @default.
• W2136360447 hasConceptScore W2136360447C177322064 @default.
• W2136360447 hasConceptScore W2136360447C185592680 @default.
• W2136360447 hasConceptScore W2136360447C202751555 @default.
• W2136360447 hasConceptScore W2136360447C207001950 @default.
• W2136360447 hasConceptScore W2136360447C26291073 @default.
• W2136360447 hasConceptScore W2136360447C2775842073 @default.
• W2136360447 hasConceptScore W2136360447C2776970183 @default.
• W2136360447 hasConceptScore W2136360447C2780231548 @default.

• next